{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:10:29Z","timestamp":1787897429715,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T00:00:00Z","timestamp":1479513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI0784 and 01KI1007B"],"award-info":[{"award-number":["01KI0784 and 01KI1007B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s15010-016-0963-2","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T03:08:20Z","timestamp":1479524900000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Risk for latent and active tuberculosis in Germany"],"prefix":"10.1007","volume":"45","author":[{"name":"For the TB or not TB consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald","family":"Bellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Diel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Goetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Heykes-Uden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Schaberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,19]]},"reference":[{"key":"963_CR1","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe. 2015. www.ecdc.europa.eu . Accessed 26 Oct 2015"},{"key":"963_CR2","unstructured":"World Health Organisation. Framework towards tuberculosis elimination in low-incidence countries [Internet].2014 http:\/\/www.who.int\/tb\/publications\/elimination_framework\/en\/ . Accessed 18 Nov 2016"},{"issue":"4","key":"963_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1183\/09031936.00201609","volume":"36","author":"CGM Erkens","year":"2010","unstructured":"Erkens CGM, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J. 2010;36(4):925\u201349.","journal-title":"Eur Respir J"},{"key":"963_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1471-2334-12-339","volume":"12","author":"TSC Hinks","year":"2012","unstructured":"Hinks TSC, Varsani N, Godsiff DT, Bull TC, Nash KL, McLuckie L, et al. High background rates of positive tuberculosis-specific interferon-\u03b3 release assays in a low prevalence region of UK: a surveillance study. BMC Infect Dis. 2012;12:339.","journal-title":"BMC Infect Dis"},{"key":"963_CR5","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, et al. Management of latent mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015;46:1563\u201376. doi: 10.1183\/13993003.01245-2015","journal-title":"Eur Respir J"},{"key":"963_CR6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmr.2012.06.005","volume":"29","author":"A Fournier","year":"2012","unstructured":"Fournier A, Antoun F, Larnaudie S. Recent latent tuberculous infection (LTBI) in different sub-groups of contacts. Rev Mal Respir. 2012;29:1079\u201387.","journal-title":"Rev Mal Respir"},{"key":"963_CR7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/039463200902200312","volume":"22","author":"G Ferrara","year":"2009","unstructured":"Ferrara G, Losi M, D\u2019Amico R, Cagarelli R, Pezzi AM, Meacci M, et al. Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. Int J Immunopathol Pharmacol. 2009;22:669\u201377.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"963_CR8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1164\/rccm.201502-0232OC","volume":"191","author":"J-P Zellweger","year":"2015","unstructured":"Zellweger J-P, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, et al. Risk assessment of tuberculosis in contacts by IFN-\u03b3 release assays. a tuberculosis network European Trials Group Study. Am J Respir Crit Care Med. 2015;191:1176\u201384.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"963_CR9","doi-asserted-by":"crossref","first-page":"e112681","DOI":"10.1371\/journal.pone.0112681","volume":"9","author":"C Gutsfeld","year":"2014","unstructured":"Gutsfeld C, Olaru ID, Vollrath O, Lange C. Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany. PLoS One. 2014;9(11):e112681.","journal-title":"PLoS One"},{"key":"963_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0030-1256439","volume":"65","author":"R Diel","year":"2011","unstructured":"Diel R, Loytved G, Nienhaus A, Castell S, Detjen A, Geerdes-Fenge H, et al. New recommendations for contact tracing in tuberculosis. Pneumologie. 2011;65:359\u201378.","journal-title":"Pneumologie"},{"key":"963_CR11","unstructured":"Bruckner E. Migration und demografischer Wandel [Internet]. G\u00fctersloh: Bertelsmann Stiftung. 2012 p. 1\u201353. https:\/\/www.bertelsmann-stiftung.de\/fileadmin\/files\/BSt\/Presse\/imported\/downloads\/xcms_bst_dms_36564_36565_2.pdf Accessed 16 Jun 2016"},{"key":"963_CR12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201406-1159OC","volume":"190","author":"R Sloot","year":"2014","unstructured":"Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. a 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med. 2014;190:1044\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"963_CR13","doi-asserted-by":"crossref","first-page":"e26199","DOI":"10.1371\/journal.pone.0026199","volume":"6","author":"DJ Christopher","year":"2011","unstructured":"Christopher DJ, James P, Daley P, Armstrong L, Isaac BTJ, Thangakunam B, et al. High annual risk of tuberculosis infection among nursing students in South India: a cohort study. PLoS One. 2011;6:e26199.","journal-title":"PLoS One"},{"key":"963_CR14","doi-asserted-by":"crossref","first-page":"e115322","DOI":"10.1371\/journal.pone.0115322","volume":"9","author":"A Schablon","year":"2014","unstructured":"Schablon A, Nienhaus A, Ringshausen FC, Preisser AM, Peters C. Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers. PLoS One. 2014;9:e115322.","journal-title":"PLoS One"},{"key":"963_CR15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-0031-1291392","volume":"65","author":"A Nienhaus","year":"2011","unstructured":"Nienhaus A, Schablon A, Tripodi D, Tripoldi D, Torres Costa J. The prevalence of latent tuberculosis infections among health-care workers\u2014a three-country comparison. Pneumol Stuttg Ger. 2011;65:726\u20139.","journal-title":"Pneumol Stuttg Ger"},{"key":"963_CR16","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.4045\/tidsskr.14.0770","volume":"135","author":"TM Arnesen","year":"2015","unstructured":"Arnesen TM, Seterelv S, Norheim G, Helgebostad SR, Manns\u00c2ker T, Ly IN, et al. Tuberculosis outbreak in Eastern Norway. Tidsskr Den Nor Laegeforening Tidsskr Prakt Med NY Raekke. 2015;135:2160\u20134.","journal-title":"Tidsskr Den Nor Laegeforening Tidsskr Prakt Med NY Raekke"},{"key":"963_CR17","first-page":"275","volume":"4","author":"L Lutong","year":"2000","unstructured":"Lutong L, Bei Z. Association of prevalence of tuberculin reactions with closeness of contact among household contacts of new smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2000;4:275\u20137.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"963_CR18","first-page":"1183","volume":"11","author":"CZ Grimes","year":"2007","unstructured":"Grimes CZ, Hwang L-Y, Williams ML, Austin CM, Graviss EA. Tuberculosis infection in drug users: interferon-gamma release assay performance. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2007;11:1183\u20139.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"963_CR19","first-page":"132406","volume":"2012","author":"TE Weant","year":"2012","unstructured":"Weant TE, Turner AN, Murphy-Weiss M, Murray DM, Wang S-H. Can social history variables predict prison inmates risk for latent tuberculosis infection? Tuberc Res Treat. 2012;2012:132406.","journal-title":"Tuberc Res Treat"},{"issue":"8","key":"963_CR20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","volume":"174","author":"JJ Saukkonen","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935\u201352.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"963_CR21","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.2105\/AJPH.2014.301897","volume":"104","author":"JP Morano","year":"2014","unstructured":"Morano JP, Zelenev A, Walton MR, Bruce RD, Altice FL. Latent tuberculosis infection screening in foreign-born populations: a successful mobile clinic outreach model. Am J Public Health. 2014;104(8):1508\u201315.","journal-title":"Am J Public Health"},{"issue":"1","key":"963_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.drugpo.2013.10.002","volume":"25","author":"K R\u00fc\u00fctel","year":"2014","unstructured":"R\u00fc\u00fctel K, Karnite A, Talu A, Abel-Ollo K, Kirvelaite G, Kliiman K, et al. Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. Int J Drug Policy. 2014;25(1):175\u20138.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"963_CR23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0954-6111(96)80008-4","volume":"86","author":"E Healy","year":"1992","unstructured":"Healy E, Kelly P, Mulcahy FM, Clancy L. AIDS, i.v. drug use and mycobacterial disease: the Dublin experience. Respir Med. 1992;86(6):491\u20134.","journal-title":"Respir Med"},{"issue":"5","key":"963_CR24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5897\/JAHR2012.050","volume":"6","author":"N Poudyal","year":"2014","unstructured":"Poudyal N, Gyawali N, Nepal HP, Gurung R, Pandey S, Amatya R, et al. Risk for developing tuberculosis among intravenous drug users with human immunodeficiency virus (HIV) infection. J AIDS HIV Res. 2014;6(5):104\u20138.","journal-title":"J AIDS HIV Res"},{"issue":"6","key":"963_CR25","first-page":"799","volume":"160","author":"ID Rusen","year":"1999","unstructured":"Rusen ID, Yuan L, Millson ME. Prevalence of mycobacterium tuberculosis infection among injection drug users in Toronto. CMAJ Can Med Assoc J J Assoc Medicale Can. 1999;160(6):799\u2013802.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"12","key":"963_CR26","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1360-0443.2001.961217777.x","volume":"96","author":"X S\u00e1nchez-Carbonell","year":"2001","unstructured":"S\u00e1nchez-Carbonell X, Vilaregut A. A 10-year follow-up study on the health status of heroin addicts based on official registers. Addict Abingdon Engl. 2001;96(12):1777\u201386.","journal-title":"Addict Abingdon Engl"},{"issue":"2","key":"963_CR27","first-page":"140","volume":"2","author":"JM Jans\u00e0","year":"1998","unstructured":"Jans\u00e0 JM, Serrano J, Cayl\u00e0 JA, Vidal R, Oca\u00f1a I, Espa\u00f1ol T. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 1998;2(2):140\u20136.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"2","key":"963_CR28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02791072.2006.10399844","volume":"38","author":"W Wang","year":"2006","unstructured":"Wang W, Xiao H, Lu L. Case-control retrospective study of pulmonary tuberculosis in heroin-abusing patients in China. J Psychoact Drugs. 2006;38(2):203\u20135.","journal-title":"J Psychoact Drugs"},{"key":"963_CR29","first-page":"378","volume":"58","author":"J Masztalerz","year":"1990","unstructured":"Masztalerz J, Miller M. The role of diabetes as a factor for increased risk of infection with tuberculosis. Pneumonol Pol. 1990;58:378\u201385.","journal-title":"Pneumonol Pol"},{"key":"963_CR30","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.2337\/dc11-0902","volume":"34","author":"A Leegaard","year":"2011","unstructured":"Leegaard A, Riis A, Kornum JB, Prahl JB, Thomsen V\u00d8, S\u00f8rensen HT, et al. Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study. Diabetes Care. 2011;34:2530\u20135.","journal-title":"Diabetes Care"},{"key":"963_CR31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.5588\/ijtld.10.0637","volume":"15","author":"SM Marks","year":"2011","unstructured":"Marks SM. Diabetes and tuberculosis, US National Health Interview Survey, 2000\u20132005. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2011;15:982\u20134.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"963_CR32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/thx.2009.128223","volume":"65","author":"C Walker","year":"2010","unstructured":"Walker C, Unwin N. Estimates of the impact of diabetes on the incidence of pulmonary tuberculosis in different ethnic groups in England. Thorax. 2010;65:578\u201381.","journal-title":"Thorax"},{"key":"963_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2105\/AJPH.87.4.574","volume":"87","author":"A Pablos-M\u00c8ndez","year":"1997","unstructured":"Pablos-M\u00c8ndez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;87:574\u20139.","journal-title":"Am J Public Health"},{"key":"963_CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCP.0b013e328351f9d6","volume":"18","author":"G Ferrara","year":"2012","unstructured":"Ferrara G, Murray M, Winthrop K, Centis R, Sotgiu G, Migliori GB, et al. Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNF\u03b1 drugs. Curr Opin Pulm Med. 2012;18:233\u201340.","journal-title":"Curr Opin Pulm Med"},{"key":"963_CR35","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00039612","volume":"40","author":"S Byberg","year":"2012","unstructured":"Byberg S, Soborg B, Andersson M, Bjerregaard P, J\u00f8rgensen ME. Diabetes is a risk factor for tuberculosis in the inuit population of Greenland. Eur Respir J. 2012;40:1289\u201391.","journal-title":"Eur Respir J"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-016-0963-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-016-0963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-016-0963-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T15:42:26Z","timestamp":1568562146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-016-0963-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1007\/s15010-016-0963-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,19]]}}}